Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

ROCKLIN, Calif. — In the middle of a suburban neighborhood in Rocklin, an unexpected sight stands out: a towering pyramid tucked away on the grounds of a golf course. The structure, an eerie reminder ...

Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex works to build markets for new drugs like Casgevy and Journavx.

Researchers in Kazakhstan discover an enigmatic 3,800-year-old structure that could have been used for funeral rituals.

Setting aside a rather brief hiccup mid-quarter, the bull market in global equities continued in force during Q4 2024. Click here to read the full commentary.

Inside the Operations That Took Captive 2 North Korean Soldiers Fighting Ukraine Experts reveal the seven odd behaviors ...

The US Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to treating ...

Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer yesterday. The company’s shares closed yesterday ...

A novel Vertex Pharmaceuticals drug that takes a new approach to pain is now approved by the FDA, a landmark decision for a first-in-class product that brings patients a treatment alternative ...

CNBC's Becky Quick reports on the latest news. Income Tax Reduced For Millions of Americans UMass Found Not Guilty After Student’s $10K Prize Money Gets Rescinded Over Halftime Contest How One ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often ...